123 Einträge | 1, 2, 3, 4, 5, 6, 7 › » |
Seite 1 / 7
![]() |
β-catenin activity in late hypertrophic chondrocytes locally orchestrates osteoblastogenesis and osteoclastogenesis. |
Houben A, Kostanova-Poliakova D, Weissenböck M, Graf J, Teufel S, von der Mark K, Hartmann C |
Development (Cambridge, England). 2016 Sep 12. pii: dev.137489. doi: 10.1242/dev.137489 |
PMID: 27621061 |
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders. |
Ringelstein M, Harmel J, Zimmermann H, Brandt AU, Paul F, Haarmann A, Buttmann M, Hümmert MW, Trebst C, Schroeder C, Ayzenberg I, Kleiter I, Hellwig K, Havla J, Kümpfel T, Jarius S, Wildemann B, Rommer P, Weber MS, Pellkofer H, Röpke L, Geis C, Retzlaff N, Zettl U, Deppe M, Klotz L, Young K, Stellmann JP, Kaste M, Kermer P, Marouf W, Lauda F, Tumani H, Graf J, Klistorner A, Hartung HP, Aktas O, Albrecht P |
Neurology. 2019 Dec 3. pii: WNL.0000000000008684. doi: 10.1212/WNL.0000000000008684 |
PMID: 31796527 |
CNS Involvement in Chronic Inflammatory Demyelinating Polyneuropathy: Subtle Retinal Changes in Optical Coherence Tomography. |
Ingwersen J, Graf J, Kluge J, Weise M, Dietrich M, Lee JI, Harmel J, Hartung HP, Ruck T, Meuth SG, Albrecht P, Aktas O, Ringelstein M |
Neurology(R) neuroimmunology & neuroinflammation. 2021 Oct 19. pii: 9/1/e1099. doi: 10.1212/NXI.0000000000001099 |
PMID: 34667130 |
Relapse-independent multiple sclerosis progression under natalizumab. |
Graf J, Leussink VI, Soncin G, Lepka K, Meinl I, Kümpfel T, Meuth SG, Hartung HP, Havla J, Aktas O, Albrecht P |
Brain communications. 2021 Oct 9. doi: 10.1093/braincomms/fcab229. pii: fcab229. pmc: PMC8573181 |
PMID: 34755108 |
Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population. |
Ng HS, Graf J, Zhu F, Kingwell E, Aktas O, Albrecht P, Hartung HP, Meuth SG, Evans C, Fisk JD, Marrie RA, Zhao Y, Tremlett H |
Frontiers in immunology. 2022 Jan 13. doi: 10.3389/fimmu.2021.794075. pmc: PMC8792855 |
PMID: 35095869 |
The degree of cortical plasticity correlates with cognitive performance in patients with Multiple Sclerosis. |
Balloff C, Penner IK, Ma M, Georgiades I, Scala L, Troullinakis N, Graf J, Kremer D, Aktas O, Hartung HP, Meuth SG, Schnitzler A, Groiss SJ, Albrecht P |
Brain stimulation. 2022 Feb 16. pii: S1935-861X(22)00035-3. doi: 10.1016/j.brs.2022.02.007 |
PMID: 35182811 |
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. |
Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF |
Lancet (London, England). 2015 May 31. pii: S0140-6736(15)60995-3. doi: 10.1016/S0140-6736(15)60995-3 |
PMID: 26040499 |
Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML--results from Study AML-BFM 2004. |
Creutzig U, Dworzak M, Zimmermann M, Bourquin JP, Gruhn B, Fleischhack G, Graf N, Klingebiel T, Kremens B, Lehrnbecher T, von Neuhoff C, von Stackelberg A, Stray J, Reinhardt D |
Klinische Pädiatrie. 2015 May 18. doi: 10.1055/s-0035-1548816 |
PMID: 25985446 |
Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells. |
Grunt TW, Hebar A, Laffer S, Wagner R, Peter B, Herrmann H, Graf A, Bilban M, Posch M, Hoermann G, Mayerhofer M, Eisenwort G, Zielinski CC, Selzer E, Valent P |
American journal of cancer research. 2015 Jan 15. pmc: PMC4396035 |
PMID: 25973297 |
Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survival. |
Creutzig U, Dworzak MN, Zimmermann M, Bourquin JP, Gruhn B, Fleischhack G, Graf N, Klingebiel T, Kremens B, Lehrnbecher T, von Neuhoff C, Stackelberg AV, Starý J, Reinhardt D |
Leukemia. 2015 Apr 14. pii: leu201594. doi: 10.1038/leu.2015.94 |
PMID: 25869725 |
Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal. |
Zagouri F, Liakou P, Bartsch R, Peccatori FA, Tsigginou A, Dimitrakakis C, Zografos GC, Dimopoulos MA, Azim HA |
Breast (Edinburgh, Scotland). 2015 Mar 25. pii: S0960-9776(15)00057-0. doi: 10.1016/j.breast.2015.02.031 |
PMID: 25818651 |
CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases. |
Stremitzer S, Stift J, Graf A, Singh J, Starlinger P, Gruenberger B, Tamandl D, Gruenberger T |
Annals of surgical oncology. 2014 Oct 17. doi: 10.1245/s10434-014-4158-8 |
PMID: 25323471 |
Pretreatment for bilateral nephroblastomatosis is an independent risk factor for progressive disease in patients with stage V nephroblastoma. |
Furtwängler R, Schmolze M, Gräber S, Leuschner I, Amann G, Schenk JP, Niggli F, Kager L, von Schweinitz D, Graf N |
Klinische Pädiatrie. 2014 May 12. doi: 10.1055/s-0034-1371840 |
PMID: 24819388 |
Low protein expression of MET in ER-positive and HER2-positive breast cancer. |
Zagouri F, Brandstetter A, Moussiolis D, Chrysikos D, Dimitrakakis C, Tsigginou A, Marinopoulos S, Zografos GC, Sergentanis TN, Dimopoulos MA, Filipits M |
Anticancer research. 2014 Mar 5. pii: 34/3/1227 |
PMID: 24596364 |
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. |
Heitzer E, Artl M, Filipits M, Resel M, Graf R, Weißenbacher B, Lax S, Gnant M, Wrba F, Greil R, Dietze O, Hofbauer F, Böhm G, Höfler G, Samonigg H, Schaberl-Moser R, Balic M, Dandachi N |
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2013 Dec 6. pii: modpathol2013204. doi: 10.1038/modpathol.2013.204 |
PMID: 24309322 |
Pertuzumab in breast cancer: a systematic review. |
Zagouri F, Sergentanis TN, Chrysikos D, Zografos CG, Filipits M, Bartsch R, Dimopoulos MA, Psaltopoulou T |
Clinical breast cancer. 2013 Jun 27. pii: S1526-8209(13)00109-2. doi: 10.1016/j.clbc.2013.05.002 |
PMID: 23810292 |
Molecularly targeted therapies in metastatic pancreatic cancer: a systematic review. |
Zagouri F, Sergentanis TN, Chrysikos D, Zografos CG, Papadimitriou CA, Dimopoulos MA, Filipits M, Bartsch R |
Pancreas. 2013 Jun 18. doi: 10.1097/MPA.0b013e31827aedef. pii: 00006676-201307000-00003 |
PMID: 23774698 |
Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series. |
Zagouri F, Sergentanis TN, Koutoulidis V, Sparber C, Steger GG, Dubsky P, Zografos GC, Psaltopoulou T, Gnant M, Dimopoulos MA, Bartsch R |
British journal of cancer. 2013 May 30. pii: bjc2013255. doi: 10.1038/bjc.2013.255. pmc: PMC3681005 |
PMID: 23722469 |
Histologic work-up of non-palpable breast lesions classified as probably benign at initial mammography and/or ultrasound (BI-RADS category 3). |
Gruber R, Jaromi S, Rudas M, Pfarl G, Riedl CC, Flöry D, Graf O, Sickles EA, Helbich TH |
European journal of radiology. 2012 Mar 18. pii: S0720-048X(12)00087-3. doi: 10.1016/j.ejrad.2012.02.004 |
PMID: 22429299 |
Standards and impact of hematopathology in myelodysplastic syndromes (MDS). |
Valent P, Orazi A, Büsche G, Schmitt-Gräff A, George TI, Sotlar K, Streubel B, Beham-Schmid C, Cerny-Reiterer S, Krieger O, van de Loosdrecht A, Kern W, Ogata K, Wimazal F, Várkonyi J, Sperr WR, Werner M, Kreipe H, Horny HP |
Oncotarget. 2011 Feb 14. pii: 101104. pmc: PMC3248141 |
PMID: 21317447 |
123 Einträge | 1, 2, 3, 4, 5, 6, 7 › » |
Seite 1 / 7
![]() |